• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性剂修饰的醇质体提高丙酸睾酮的经皮生物利用度。

Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes.

机构信息

Liaoning Research Institute of Family Planning, Shenyang, Liaoning Province, People's Republic of China.

出版信息

Int J Nanomedicine. 2013;8:3051-60. doi: 10.2147/IJN.S46748. Epub 2013 Aug 13.

DOI:10.2147/IJN.S46748
PMID:23990718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3748904/
Abstract

The current investigation aimed to evaluate the transdermal potential of novel testosterone propionate (TP) ethosomes and liposomes prepared by surfactant modification. The effect of hexadecyl trimethyl ammonium bromide and cremophor EL-35 on the particle size and zeta potential of the prepared vesicles was investigated. The entrapment efficiency and stability, as well as in vitro and in vivo skin permeation, were studied with the various techniques, such as differential scanning calorimetry, confocal laser scanning microscopy, transmission electron microscopy, dynamic light scattering, and so on. The results indicated that the ethosomes were defined as spherical, unilamellar structures with low polydispersity (0.100 ± 0.015) and nanometric size (156.5 ± 3.5 nm). The entrapment efficiency of TP in ethosomal and liposomal carriers was 92.7% ± 3.7% and 64.7% ± 2.1%, respectively. The stability profile of the prepared TP ethosomal system assessed for 120 days revealed very low aggregation and very low growth in vesicular size. TP ethosomes also provided an enhanced transdermal flux of 37.85 ± 2.8 μg/cm(2)/hour and a decreased lag time of 0.18 hours across mouse skin. The skin permeation efficiency of the TP ethosomes as further assessed by confocal laser scanning microscopy revealed enhanced permeation of rhodamine red-loaded formulations to the deeper layers of the skin (260 μm) than that of the liposomal formation (120 μm).

摘要

本研究旨在评估新型睾酮丙酸(TP)醇质体和由表面活性剂修饰制备的脂质体的经皮潜力。考察了十六烷基三甲基溴化铵和吐温 EL-35 对所制备囊泡的粒径和 zeta 电位的影响。采用差示扫描量热法、共聚焦激光扫描显微镜、透射电子显微镜、动态光散射等多种技术研究了包封率和稳定性,以及体外和体内皮肤渗透。结果表明,醇质体呈球形、单分子层结构,具有低多分散性(0.100 ± 0.015)和纳米级粒径(156.5 ± 3.5nm)。TP 醇质体和脂质体载体的包封率分别为 92.7% ± 3.7%和 64.7% ± 2.1%。对制备的 TP 醇质体系统进行了 120 天的稳定性评估,结果表明其聚集程度非常低,囊泡粒径增长非常低。TP 醇质体还提供了增强的 37.85 ± 2.8μg/cm(2)/小时的经皮通量和 0.18 小时的滞后时间,从而减少了穿过小鼠皮肤的药物传输。通过共聚焦激光扫描显微镜进一步评估 TP 醇质体的皮肤渗透效率,结果表明,与脂质体制剂相比,罗丹明红负载制剂更能渗透到皮肤的深层(260μm)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/28e3858cc092/ijn-8-3051Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/1868419e958a/ijn-8-3051Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/c5661f054554/ijn-8-3051Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/9ebd66bb871f/ijn-8-3051Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/a998421d07d0/ijn-8-3051Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/d988e6172cfe/ijn-8-3051Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/6aa1003906f6/ijn-8-3051Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/28e3858cc092/ijn-8-3051Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/1868419e958a/ijn-8-3051Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/c5661f054554/ijn-8-3051Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/9ebd66bb871f/ijn-8-3051Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/a998421d07d0/ijn-8-3051Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/d988e6172cfe/ijn-8-3051Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/6aa1003906f6/ijn-8-3051Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7ed/3748904/28e3858cc092/ijn-8-3051Fig7.jpg

相似文献

1
Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes.表面活性剂修饰的醇质体提高丙酸睾酮的经皮生物利用度。
Int J Nanomedicine. 2013;8:3051-60. doi: 10.2147/IJN.S46748. Epub 2013 Aug 13.
2
High-efficient nano-carrier gel systems for testosterone propionate skin delivery.用于丙酸睾酮经皮递送的高效纳米载体凝胶系统。
Pharm Dev Technol. 2015;20(6):724-9. doi: 10.3109/10837450.2014.915573. Epub 2014 May 6.
3
Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.载褪黑素乙醇脂质体:理化特性及增强的透皮递送
Eur J Pharm Biopharm. 2007 Sep;67(2):398-405. doi: 10.1016/j.ejpb.2007.03.007. Epub 2007 Mar 14.
4
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.通过乙醇脂质体进行抗银屑病药物的真皮和透皮给药。
J Control Release. 2007 Nov 6;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. Epub 2007 Aug 16.
5
Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.醇质体——用于增强递送的新型囊泡载体:表征及皮肤渗透特性
J Control Release. 2000 Apr 3;65(3):403-18. doi: 10.1016/s0168-3659(99)00222-9.
6
Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.醇质体促进亲脂性药物经皮渗透的机制。
Int J Nanomedicine. 2017 Apr 26;12:3357-3364. doi: 10.2147/IJN.S134708. eCollection 2017.
7
Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.通过弹性脂质体增强阿昔洛韦钠的经皮递送。
Drug Deliv. 2008 Mar-Apr;15(3):141-7. doi: 10.1080/10717540801952407.
8
Tailoring novel soft nano-vesicles 'Flexosomes' for enhanced transdermal drug delivery: Optimization, characterization and comprehensive ex vivo - in vivo evaluation.定制新型软纳泡 'Flexosomes' 以增强经皮药物传递:优化、表征和全面的离体 - 体内评估。
Int J Pharm. 2019 Apr 5;560:101-115. doi: 10.1016/j.ijpharm.2019.01.072. Epub 2019 Feb 10.
9
Nanosized ethosomal dispersions for enhanced transdermal delivery of nebivolol using intradermal/transfollicular sustained reservoir: evaluation, confocal laser scanning microscopy, and pharmacokinetic studies.纳米乙基皂传递体分散体经皮传递比索洛尔的研究:皮内/经毛囊持续储库的评价、共聚焦激光扫描显微镜和药代动力学研究。
Pharm Dev Technol. 2024 Jan;29(1):40-51. doi: 10.1080/10837450.2023.2294278. Epub 2023 Dec 19.
10
Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation.脂质体、醇质体和传递体作为增强双氯芬酸经皮传递的载体的比较研究:体外和体内评价。
Int J Pharm. 2019 May 30;563:293-303. doi: 10.1016/j.ijpharm.2019.04.001. Epub 2019 Apr 2.

引用本文的文献

1
Wound Healing Efficacy of Rosuvastatin Transethosomal Gel, I Optimal Optimization, Histological and In Vivo Evaluation.瑞舒伐他汀转质体凝胶的伤口愈合功效,I. 优化、组织学及体内评估
Pharmaceutics. 2022 Nov 19;14(11):2521. doi: 10.3390/pharmaceutics14112521.
2
Tailoring of Retinyl Palmitate-Based Ethosomal Hydrogel as a Novel Nanoplatform for Acne Vulgaris Management: Fabrication, Optimization, and Clinical Evaluation Employing a Split-Face Comparative Study.基于视黄醇棕榈酸酯的乙基素水凝胶的定制作为一种治疗寻常痤疮的新型纳米平台:采用分割面比较研究的制剂、优化和临床评估。
Int J Nanomedicine. 2021 Jun 24;16:4251-4276. doi: 10.2147/IJN.S301597. eCollection 2021.
3

本文引用的文献

1
Comparative study on preparative methods of DC-Chol/DOPE liposomes and formulation optimization by determining encapsulation efficiency.载药 DC-Chol/DOPE 脂质体的制备方法比较研究及包封率测定的处方优化
Int J Pharm. 2012 Sep 15;434(1-2):155-60. doi: 10.1016/j.ijpharm.2012.05.041. Epub 2012 May 27.
2
Preparation and Characterization of Ethosomes for Topical delivery of Aceclofenac.用于醋氯芬酸局部给药的醇质体的制备与表征
Indian J Pharm Sci. 2010 Sep;72(5):582-6. doi: 10.4103/0250-474X.78524.
3
Approved hormonal treatments for HSDD: an unmet medical need.
Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations.
醇质体作为用于开发经皮给药制剂的纳米载体。
Pharm Res. 2021 Jun;38(6):947-970. doi: 10.1007/s11095-021-03053-5. Epub 2021 May 25.
4
Mitigation of Rheumatic Arthritis in a Rat Model via Transdermal Delivery of Dapoxetine HCl Amalgamated as a Nanoplatform: In vitro and in vivo Assessment.经皮递送盐酸达泊西汀共混纳米平台减轻大鼠风湿性关节炎:体外与体内评估。
Int J Nanomedicine. 2020 Mar 6;15:1517-1535. doi: 10.2147/IJN.S238709. eCollection 2020.
5
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery.蛋白质药物递送的非侵入性制剂的最新进展
Comput Struct Biotechnol J. 2019 Sep 11;17:1290-1308. doi: 10.1016/j.csbj.2019.09.004. eCollection 2019.
6
Paeonol-Loaded Ethosomes as Transdermal Delivery Carriers: Design, Preparation and Evaluation.丹皮酚醇质体经皮给药载体的设计、制备与评价
Molecules. 2018 Jul 17;23(7):1756. doi: 10.3390/molecules23071756.
7
Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation.转乙磺酰体凝胶作为秋水仙碱经皮给药的载体:统计优化、表征及体外评价
Drug Des Devel Ther. 2018 Apr 9;12:795-813. doi: 10.2147/DDDT.S158018. eCollection 2018.
8
Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate.用于增强甲磺酸依普罗沙坦透皮递送的新型软纳米囊泡的制备与表征
Saudi Pharm J. 2017 Nov;25(7):1040-1046. doi: 10.1016/j.jsps.2017.01.006. Epub 2017 Feb 2.
9
Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.乙醇胺纳米载体:成分和制剂技术对乙醇胺纳米粒性质、体内研究及临床试验的影响
Int J Nanomedicine. 2016 May 25;11:2279-304. doi: 10.2147/IJN.S105016. eCollection 2016.
10
Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement.复方抗疟乙脂质巴布剂:制备、评价及渗透促进机制
Int J Nanomedicine. 2015 Jun 30;10:4239-53. doi: 10.2147/IJN.S83402. eCollection 2015.
批准用于 HSDD 的激素治疗:未满足的医学需求。
J Sex Med. 2009 Jul;6(7):1846-9. doi: 10.1111/j.1743-6109.2009.01294.x. Epub 2009 Apr 24.
4
In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.使用囊泡乙醇脂质体载体的非那雄胺体外经皮渗透及皮肤蓄积情况
AAPS PharmSciTech. 2008;9(3):860-5. doi: 10.1208/s12249-008-9124-y. Epub 2008 Jul 23.
5
Testosterone depot injection in male hypogonadism: a critical appraisal.男性性腺功能减退的睾酮长效注射剂:批判性评估
Clin Interv Aging. 2007;2(4):577-90.
6
Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.载褪黑素乙醇脂质体:理化特性及增强的透皮递送
Eur J Pharm Biopharm. 2007 Sep;67(2):398-405. doi: 10.1016/j.ejpb.2007.03.007. Epub 2007 Mar 14.
7
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.用于皮肤给药的脂质囊泡:三十年研究综述
Int J Pharm. 2007 Mar 6;332(1-2):1-16. doi: 10.1016/j.ijpharm.2006.12.005. Epub 2006 Dec 8.
8
Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.可变形脂质体与醇质体:增强皮肤给药的机制
Int J Pharm. 2006 Sep 28;322(1-2):60-6. doi: 10.1016/j.ijpharm.2006.05.027. Epub 2006 May 19.
9
Elastic liposomes mediated transcutaneous immunization against Hepatitis B.弹性脂质体介导的乙肝经皮免疫
Vaccine. 2006 May 29;24(22):4847-55. doi: 10.1016/j.vaccine.2006.03.011. Epub 2006 Mar 15.
10
Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.一种松果体激素的经皮递送:通过弹性脂质体递送褪黑素。
Biomaterials. 2006 Jun;27(18):3491-6. doi: 10.1016/j.biomaterials.2006.01.060. Epub 2006 Mar 2.